Neurocognitive performance in family-based and case-control studies of schizophrenia

Schizophrenia Research

Volumn 163, Issue 1-3, 2015, Pages 17-23

  Gur, Ruben C ^a   Braff, David L ^b,c   Calkins, Monica E ^a   Dobie, Dorcas J ^d,e   Freedman, Robert ^f   Green, Michael F ^g,h   Greenwood, Tiffany A ^b,c   Lazzeroni, Laura C ⁱ   Light, Gregory A ^b,c   Nuechterlein, Keith H ^g,h   Olincy, Ann ^f   Radant, Allen D ^d,e   Seidman, Larry J ^j,k   Siever, Larry J ^l,m   Silverman, Jeremy M ^l,m   Sprock, Joyce ^b,c   Stone, William S ^j,k   Sugar, Catherine A ^c   Swerdlow, Neal R ^b,c   Tsuang, Debby W ^d,e   Tsuang, Ming T ^b,c   Turetsky, Bruce I ^a   Gur, Raquel E ^a   more..

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^f UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

ⁱ STANFORD UNIVERSITY   (United States)

^j HARVARD MEDICAL SCHOOL   (United States)

^k BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^l MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Ascertainment; Case control; Family based; Neurocognition; Schizophrenia

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COMPUTERIZED NEUROCOGNITIVE BATTERY; CONTROLLED STUDY; DISEASE SEVERITY; EXECUTIVE FUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; PERFORMANCE MEASUREMENT SYSTEM; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; SCHIZOPHRENIA; SENSITIVITY ANALYSIS; ADOLESCENT; CLINICAL TRIAL; COMPUTER; ENDOPHENOTYPE; EPIDEMIOLOGY; FAMILY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; COMPUTERS; ENDOPHENOTYPES; EPIDEMIOLOGIC RESEARCH DESIGN; FAMILY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84925852156     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.10.049     Document Type: Article

References (43)

1. Agnew-Blais J., Siedman L.J. Neurocognition in youth adults under age 30 at familial risk for schizophrenia: a quantitative and qualitative review. Cogn. Neuropsychiatry 2013, 18(1-2):44-82.
2. Andreasen N.C. Scale for the Assessment of Negative Symptoms (SANS) 1984, University of Iowa, Iowa City, Iowa.
3. Andreasen N.C. Scale for the Assessment of Positive Symptoms (SAPS) 1984, University of Iowa, Iowa City, Iowa.
4. Braff D.L. The importance of endophenotypes in schizophrenia research: past, present and future. Schizophr. Res. 2015, 163(1-3):1-8. (in this issue).
5. Braff D.L., Freedman R., Schork N.J., Gottesman I.I. Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr. Bull. 2007, (33):21-32.
6. Calkins M.E., Tepper P., Gur R.C., Ragland J.D., Klei L., Wiener H.W., Richard J., Savage R.M., Allen T.B., O'Jile J., Devlin B., Kwentus J., Aliyu M.H., Bradford L.D., Edwards N., Lyons P.D., Nimgaonkar V.L., Santos A.B., Go R.C., Gur R.E. Project among African-Americans to explore risks for schizophrenia (PAARTNERS): evidence for impairment and heritability of neurocognitive functioning in families of schizophrenia patients. Am. J. Psychiatry 2010, 167(4):459-472.
7. Calkins M.E., Ray A., Gur R.C., Freedman R., Green M.F., Greenwood T.A., Light G.A., Nuechterlein K.H., Olincy A., Radant A.D., Seidman L.J., Siever L.J., Silverman J.M., Stone W.S., Sugar C., Swerdlow N.R., Tsuang D.W., Tsuang M.T., Turetsky B.I., Braff D.L., Lazzeroni L.C., Gur R.E. Sex differences in familiality effects on neurocognitive performance in schizophrenia. Biol. Psychiatry 2013, 73(10):976-984.
8. Da Silva F.N., Irani F., Richard J., Brensinger C.M., Bilker W.B., Gur R.E., Gur R.C. More than just tapping: index finger-tapping measures procedural learning in schizophrenia. Schizophr. Res. 2012, 137(1-3):234-240.
9. Faraone S.V., Green A., Seidman L.J., Tsuang M.T. "Schizotaxia": clinical implications and new directions for research. Schizophr. Bull. 2001, 27(1):1-18.
10. Glahn D.C., Knowles E.E., McKay D.R., Sprooten E., Raventós H., Blangero J., Gottesman I.I., Almasy L. Arguments for the sake of endophenotypes: examining common misconceptions about the use of endophenotypes in psychiatric genetics. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2014, 165B(2):122-130.
11. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 2003, 160(4):636-645.
12. Greenwood T.A., Braff D.L., Light G.A., Cadenhead K.S., Calkins M.E., Dobie D.J., Freedman R., Green M.F., Gur R.E., Gur R.C., Mintz J., Nuechterlein K.H., Olincy A., Radant A.D., Seidman L.J., Siever L.J., Silverman J.M., Stone W.S., Swerdlow N.R., Tsuang D.W., Tsuang M.T., Turetsky B.I., Schork N.J. Initial heritability analyses of endophenotypic measures for schizophrenia: the Consortium on the Genetics of Schizophrenia. Arch. Gen. Psychiatry 2007, 64(11):1242-1250.
13. Greenwood T.A., Lazzeroni L.C., Murray S.S., Cadenhead K.S., Calkins M.E., Dobie D.J., Green M.F., Gur R.E., Gur R.C., Hardiman G., Kelsoe J.R., Leonard S., Light G.A., Neuchterlein K.H., Olincy A., Radant A.D., Schork N.J., Seidman L.J., Siever L.J., Silverman J.M., Stone W.S., Swerdlow N.R., Tsuang D.W., Turetsky B.I., Freedman R., Braff D.L. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am. J. Psychiatry 2011, 168(9):930-946.
14. Greenwood T.A., Swerdlow N.R., Gur R.E., Cadenhead K.S., Calkins M.E., Dobie D.J., Freedman R., Green M.F., Gur R.C., Lazzeroni L.C., Nuechterlein K.H., Olincy A., Radant A.D., Ray A., Schork N.J., Seidman L.J., Siever L.J., Silverman J.M., Stone W.S., Sugar C.A., Tsuang D.W., Tsuang M.T., Turetsky B.I., Light G.A., Braff D.L. Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am. J. Psychiatry 2013, (170):521-532.
15. Gur R.C., Ragland J., Moberg P., Turner T., Bilker W.B., Kohler C., Siegel S.J., Gur R.E. Computerized neurocognitive scanning: I. Methodology and validation in healthy people. Neuropsychopharmacology 2001, 25(5):766-776.
16. Gur R.C., Ragland J.D., Moberg P.J., Bilker W.B., Kohler C., Siegel S.J., Gur R.E. Computerized neurocognitive scanning: II. The profile of schizophrenia. Neuropsychopharmacology 2001, 25(5):777-788.
17. Gur R.E., Nimgaonkar V.L., Almasy L., Calkins M.E., Ragland J.D., Pogue-Geile M.F., Kanes S., Blangero J., Gur R.C. Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia. Am. J. Psychiatry 2007, 164(5):813-819.
18. Gur R.E., Calkins M.E., Gur R.C., Horan W.P., Nuechterlein K.H., Seidman L.J., Stone W.S. The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes. Schizophr. Bull. 2007, 33(1):49-68.
19. Gur R.C., Richard J., Hughett P., Calkins M.E., Macy L., Bilker W.B., Brensinger C., Gur R.E. A cognitive neuroscience-based computerized battery for efficient measurement of individual differences: standardization and initial construct validation. J. Neurosci. Methods 2010, 187(2):254-262.
20. Gur R.C., Richard J., Calkins M.E., Chiavacci R., Hansen J.A., Bilker W.B., Loughead J., Connolly J.J., Qiu H., Mentch F.D., Abou-Sleiman P.M., Hakonarson H., Gur R.E. Age group and sex differences in performance on a computerized neurocognitive battery in children age 8-21. Neuropsychology 2012, 26(2):251-265.
21. Hall R.C., Parks J. The modified global assessment of functioning scale: addendum. Psychosomatics 1995, 36(4):416-417.
22. Hiekkalinna T., Gorring H.H., Lambert B., Weiss K.M., Norrgrann P., Scharffer A.A., Terwilligeret J.D. On the statistical properties of family-based association tests in datasets containing both pedigrees and unrelated case-control samples. Eur. J. Hum. Genet. 2012, (20):217-223.
23. Irani F., Brensinger C.M., Richard J., Calkins M.E., Moberg P.J., Bilker W., Gur R.E., Gur R.C. Computerized neurocognitive test performance in schizophrenia: a lifespan analysis. Am. J. Geriatr. Psychiatry 2012, 20(1):41-52.
24. Keshavan M., Kulkarni S., Bhojraj T., Francis A., Diwadkar V., Montrose D., Seidman L.J., Sweeney J. Premorbid cognitive deficits in young relatives of schizophrenia patients. Front. Hum. Neurosci. 2010, 62(3):1-14.
25. Kremen W., Hoff A. Neurocognitive deficits in biological relatives of individuals with schizophrenia. Early Clinical Intervention and Prevention in Schizophrenia 2004, 133-154. Humana Press, Totowa, NJ. W. Stone, S. Faraone, M.M. Tsuang (Eds.).
26. Lee J., Green M.F., Calkins M.E., Greenwood T.A., Gur R.E., Gur R.C., Lazzeroni L.C., Light G.A., Nuechterlein K.H., Radant A.D., Seidman L.J., Siever L.J., Silverman J.M., Sprock J., Stone W.S., Sugar C.A., Swerdlow N.R., Tsuang D.W., Tsuang M.T., Turetsky B.I., Braff D.L. Verbal working memory in schizophrenia: the moderating role of smoking status and antipsychotic medications. Schizophr. Res. 2015, 163(1-3):24-31. (in this issue).
27. Light G.A., Greenwood T.A., Swerdlow N.R., Calkins M.E., Freedman R., Green M.F., Gur R.E., Gur R.C., Lazzeroni L.C., Nuechterlein K.H., Olincy A., Radant A.D., Seidman L.J., Siever L.J., Silverman J.M., Sprock J., Stone W.S., Sugar C.A., Tsuang D.W., Tsuang M.T., Turetsky B.I., Braff D.L. Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study. Schizophr. Bull. 2014, (in press).
28. Light G.A., Swerdlow N.R., Thomas M.L., Calkins M.E., Green M.F., Greenwood T.A., Gur R.E., Gur R.C., Lazzeroni L.C., Nuechterlein K.H., Pela M., Radant A.D., Seidman L.J., Sharp R.F., Siever L.J., Silverman J.M., Sprock J., Stone W.S., Sugar C.A., Tsuang D.W., Tsuang M.T., Braff D.L., Turetsky B.I. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in the COGS-2. Schizophr. Res. 2015, 163(1-3):63-72. (in this issue).
29. Meehl P.E. Nuisance variables and the ex post facto design. Minnesota Studies in the Philosophy of Science 1970, 373-402. University of Minnesota Press, Minneapolis. M. Radner, S. Winokur (Eds.).
30. Moore T.M., Reise S.T., Gur R.E., Hakonarson H., Gur R.C. Psychometric properties of the Penn Computerized Neurocognitive Battery. Neuropsychology 2014, (in press) [Epub ahead of print].
31. Niemi L., Suvisaari J., Tuulio-Henriksson A., Lonnqvist J. Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies. Schizophr. Res. 2003, 60(2-3):239-258.
32. Nuechterlein K.H., Subotnik K.L., Green M.F., Ventura J., Asarnow R.F., Gitlin M.J., Yee C.M., Gretchen-Doorly D., Mintz J. Neurocognitive predictors of work outcome in recent-onset schizophrenia. Schizophr. Bull. 2011, 37(Suppl. 2):S33-S40.
33. Nuechterlein K.H., Green M.F., Calkins M.E., Greenwood T.A., Gur R.E., Gur R.C., Lazzeroni L.C., Light G.A., Radant A.D., Seidman L.J., Siever L.J., Silverman J.M., Sprock J., Stone W.S., Sugar C.A., Swerdlow N.R., Tsuang D.W., Tsuang M.T., Turetsky B.I., Braff D.L. Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS). Schizophr. Res. 2015, 163(1-3):38-46. (in this issue).
34. Resnick S.M. Matching for education in studies of schizophrenia. Arch. Gen. Psychiatry 1992, 49(3):246.
35. Roalf D.R., Ruparel K., Gur R.E., Bilker W., Gerraty R., Elliott M.A., Gallagher R.S., Almasy L., Pogue-Geile M.F., Prasad K., Wood J., Nimgaonkar V.L., Gur R.C. Neuroimaging predictors of cognitive performance across a standardized neurocognitive battery. Neuropsychology 2014, 28(2):161-176.
36. Seidman L.J., Giuliano A.J., Smith C.W., Stone W.S., Glatt S.J., Meyer E., Faraone S.V., Tsuang M.T., Cornblatt B. Neuropsychological functioning in adolescents and young adults at genetic risk for schizophrenia and affective psychoses: results from the Harvard and Hillside Adolescent High Risk Studies. Schizophr. Bull. 2006, 32(3):507-524.
37. Sitskoorn M.M., Aleman A., Ebisch S.J., Appels M.C., Kahn R.S. Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis. Schizophr. Res. 2004, 71(2-3):285-295.
38. Snitz B.E., Macdonald A.W., Carter C.S. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr. Bull. 2006, 32(1):179-194.
39. Stone W.S., Braff D.L., Calkins M.E., Green M.F., Greenwood T.A., Gur R.E., Gur R.C., Lazzeroni L.C., Light G.A., Nuechterlein K.H., Radant A.D., Siever L.J., Silverman J.M., Sprock J., Sugar C.A., Swerdlow N.R., Tsuang D.W., Tsuang M.T., Turetsky B.I., Seidman L.J. California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: Comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS). Schizophr. Res. 2015, 163(1-3):32-37. (in this issue).
40. Swerdlow N.R., Light G.A., Sprock J., Calkins M.E., Green M.F., Greenwood T.A., Gur R.E., Gur R.C., Lazzeroni L.C., Nuechterlein K.H., Radant A.D., Ray A., Seidman L.J., Siever L.J., Silverman J.M., Stone W.S., Sugar C.A., Tsuang D.W., Tsuang M.T., Turestsky B.I., Braff D.L. Deficient prepulse inhibition in schizophrenia detected by the multi-site Consortium on the Genetics in Schizophrenia. Schizophr. Res. 2014, (152):503-512.
41. Swerdlow N.R., Gur R.E., Braff D.L. Consortium on the Genetics of Schizophrenia (COGS) assessment of endophenotypes for schizophrenia: an introduction to this special issue of Schizophrenia Research. Schizophr. Res. 2015, 163(1-3):9-16. (in this issue).
42. Turetsky B.I., Dress E.M., Braff D.L., Calkins M.E., Green M.F., Greenwood T.A., Gur R.E., Gur R.C., Lazzeroni L.C., Nuechterlein K.H., Radant A.D., Seidman L.J., Sieve L.J., Silverman J.M., Sprock J., Stone W.S., Sugar C.A., Swerdlow N.R., Tsuang D.W., Ming T., Tsuang M.T., Light G.A. The utility of P300 as a schizophrenia endophenotype and predictive biomarker: Clinical and socio-demographic modulators in COGS-2. Schizophr. Res. 2015, 163(1-3):53-62. (in this issue).
43. Wilkinson G.S., Robertson G.J. Psychological Assessment Resources. WRAT4 Introductory Kit 2006, Fourth edition. F.L. Lutz (Ed.).